研究開発費、抱合せ株式消滅差益、Transfer To Other Capital Surplus From Legal Capital SurplusCS他1件
- 【期間】
| 年度 | 研究開発費 | 抱合せ株式消滅差益 | Transfer To Other Capital Surplus From Legal Capital SurplusCS | 自己株式 |
|---|
| 2008/03 | 31百万 | | - | | - | | - | |
| 2009/03 | - | | - | | - | | -16,000 | |
| 2010/03 | - | | - | | - | | -16,000 | ±0% |
| 2011/03 | - | | - | | - | | -26,000 | 赤拡 |
| 2012/03 | - | | - | | - | | -26,000 | ±0% |
| 2013/03 | 24百万 | -23.2% | - | | - | | -26,000 | ±0% |
| 2014/03 | 123百万 | +410.4% | - | | - | | -26,000 | ±0% |
| 2015/03 | 89百万 | -27.2% | 30百万 | | - | | -26,000 | ±0% |
| 2016/03 | 92百万 | +2.4% | - | | - | | -26,000 | ±0% |
| 2017/03 | 84百万 | -8.6% | - | | - | | -26,000 | ±0% |
| 2018/03 | 119百万 | +42.4% | - | | - | | -26,000 | ±0% |
| 2019/03 | 62百万 | -47.7% | 49百万 | +60.4% | - | | -90,000 | 赤拡 |
| 2020/03 | 75百万 | +19.6% | - | | - | | -90,000 | ±0% |
| 2021/03 | 154百万 | +106.6% | - | | - | | -90,000 | ±0% |
| 2022/03 | 177百万 | +14.9% | - | | - | | -90,000 | ±0% |
| 2023/03 | 206百万 | +16.2% | - | | - | | -0.11百万 | 赤拡 |
| 2024/03 | - | | - | | - | | -0.13百万 | 赤拡 |
